Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Biologic Trials

Colorectal cancer biologic therapy studies

Colorectal cancer biologic therapy trials start with a conversation

Colorectal Biologic Trials lists colorectal cancer studies that test a biologic. That can be a vaccine, an antibody, or a cell or gene therapy. You can see which studies are recruiting and be connected with a study team. The first step is a short conversation. It costs nothing and carries no obligation.

Call (888) 413-6546
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed
A row of sealed glass vials on a laboratory instrument
Photo by Jess Loiterton on Pexels
All locations

Colorectal cancer biologic therapy studies in numbers

colorectal cancer biologic therapy studies recruiting in the U.S.
43
states with a study site
41
cities with a study site
308

Source: ClinicalTrials.gov. Data processed .

Find colorectal cancer biologic therapy studies near you

These states have the most studies recruiting right now.

Colorectal cancer biologic therapy studies recruiting now

As of November 18, 2026, 43 colorectal cancer biologic therapy studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry. This is what they have in common.

What they test

  • biologics such as vaccines or antibodies43
  • medications22
  • procedures12
  • other approaches4
  • devices1

A study can test more than one.

Main purpose

  • treating a condition42
  • other purposes1

Phase

  • Phase 117
  • Phase 1/211
  • Phase 27
  • Phase 38

Who runs them

  • industry22
  • university, hospital or other13
  • government8

Who they enroll

  • adults (18 to 64)43
  • older adults (65 and over)43

Where: sites in 41 states. The cities with the most are Houston, TX (15), Los Angeles, CA (13), New York, NY (13), Atlanta, GA (8), Grand Rapids, MI (8), Nashville, TN (8), San Antonio, TX (8), Aurora, CO (7).

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 43 studies.

Recently updated colorectal cancer biologic therapy studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Allentown, PA · Ann Arbor, MI · Atlanta, GA · and 42 more U.S. locations
    Registry record
    NCT05863195 · updated
  2. A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    SOTIO Biotech a.s.
    Recruiting in
    Fairfax, VA · Houston, TX
    Registry record
    NCT07693751 · updated
  3. Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

    • Phase 2
    • Ages 18 to 72
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Bethesda, MD
    Registry record
    NCT01174121 · updated
  4. A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Atlanta, GA · Baltimore, MD · Billings, MT · and 45 more U.S. locations
    Registry record
    NCT06997497 · updated
  5. Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Exelixis
    Recruiting in
    Bridgewater, NJ · Council Bluffs, IA · East Brunswick, NJ · and 11 more U.S. locations
    Registry record
    NCT07750158 · updated
  6. Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Aurora, CO · Charlottesville, VA · Columbus, OH · and 7 more U.S. locations
    Registry record
    NCT06102902 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in the United States on ClinicalTrials.gov.

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and some of the places it is recruiting) exactly as registered. Nothing in a record is reworded. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry.

Colorectal Biologic Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Not sure which study fits?

Tell a coordinator what you are looking for. They will explain which colorectal cancer biologic therapy studies may be worth a closer look and what the next step is. Asking does not commit you to anything.

Call (888) 413-6546

What colorectal cancer biologic therapy studies look at

Every study listed here tests a biologic in colorectal cancer. A biologic can be a vaccine, an antibody, or a cell or gene therapy. Each study is built to answer one specific question. Because of that, what you would be asked to do varies between studies.

Whatever a study is testing is investigational. Researchers are still learning how well it works and what its risks are. That is why the study exists.

Who may be able to take part

Requirements are set separately for every colorectal cancer biologic trial. A trial may consider how old you are, your medical past, and the medicines you take now. It may also consider how you are affected by the condition. Certain trials are open to people without the condition as well.

Sorting out whether you fit is the study team's task, not yours. They review that when you come in for a screening visit. Read about eligibility and screening.

How taking part works

This process has four steps. Going on to the next one is your call every time.

  1. Tell us what you are looking for

    You begin with a call or a short form. You say which colorectal cancer biologic study, or kind of biologic, interests you.

  2. Talk with a coordinator

    You hear from a coordinator about the biologic trials that could fit you. Anything you ask gets a plain-language answer.

  3. Meet the study team

    This step happens only if you choose to go on. The study team goes over the trial with you point by point. Your eligibility is reviewed then too.

  4. Decide what is right for you

    Participation stays voluntary from start to finish. You may withdraw from a trial on any day, whatever your reason.

Why people take part in colorectal cancer biologic therapy studies

Reasons for joining a colorectal cancer biologic trial vary from person to person. Whatever yours is, it is worth talking through before you decide.

  • Close health monitoring by a research team while the trial runs.
  • A better understanding of colorectal cancer, for those living with it.
  • A chance to contribute to research questions whose answers could influence future care for others.

Research and treatment are different things, and a trial is research. Nobody can tell you that joining will benefit you personally. Our page on what a clinical trial is explains this in simple terms.

Your safety and your rights come first

An independent ethics committee must review each trial before a single person can enroll. You are also given written details first, and only then asked to agree. Our guides explain the informed consent process and the review and monitoring of trials. They also set out the rights that stay with you throughout.

Common questions about colorectal cancer biologic therapy studies

Do I need a diagnosis to join a study about colorectal cancer?

Diagnosis rules differ from one colorectal cancer biologic trial to the next. Some trials want your diagnosis confirmed before you join. In other trials, staff assess you as part of screening. You will hear from the study team what applies in your case.

Would I have to change the care I receive now?

Please do not change any of your care by yourself. Some studies let current care continue. Others do not. The study doctor goes over this with you. You can also discuss it with your own doctor before you decide.

Is there a cost to take part?

In general, a participant pays nothing for trial visits, trial tests, or the biologic under study. See the full details on costs.

Does it cost anything to ask about a study?

No. There is no charge for a conversation with Colorectal Biologic Trials. A question is only a question, and it enrolls you in nothing.

Do I have to take part if I call?

No. Each stage goes ahead only if you choose it. Stopping is open to you whenever you want.

Who decides whether I can join a study?

Eligibility for a colorectal cancer biologic trial is decided by its study team. You attend a screening visit first, and their answer comes after it. Requirements are set separately for every trial. Read how screening works.

Ask about colorectal cancer biologic therapy studies

You begin by giving us some basic information. A coordinator then gets in touch. Asking creates no obligation of any kind.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Learn more from independent sources

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 413-6546

or send a short form

How should we reach you?

Call